Resolving lipoxin A4: Endogenous mediator or exogenous anti-inflammatory agent? [PDF]
McGuffee RM, Luetzen MA, Ford DA.
europepmc +1 more source
Molecular Mechanisms Underlying Burn-Injury Induced Pain: From Inflammation to Epigenetics. [PDF]
Sosanya NM +5 more
europepmc +1 more source
Impact of Specialized Pro-Resolving Lipid Mediators on Craniofacial and Alveolar Bone Regeneration: Scoping Review. [PDF]
Rovai EDS +5 more
europepmc +1 more source
Deciphering the Potential Role of Specialized Pro-Resolving Mediators in Obesity-Associated Metabolic Disorders. [PDF]
Kim N, Shin HY.
europepmc +1 more source
Resolvins Revisited: Methodological and Translational Gaps. Comment on Ghemiș et al. The Involvement of Resolvins in Pathological Mechanisms of Periodontal Disease Associated with Type 2 Diabetes: A Narrative Review. <i>Int. J. Mol. Sci.</i> 2024, <i>25</i>, 12784. [PDF]
Kriventsov MA, Neprelyuk OA.
europepmc +1 more source
The Role of Endogenous Specialized Proresolving Mediators in Mast Cells and Their Involvement in Inflammation and Resolution. [PDF]
Fukuishi N +4 more
europepmc +1 more source
The tumor microenvironment: adding pieces to the puzzle. [PDF]
Aguilar-Cazares D +6 more
europepmc +1 more source
Attenuation of adipose tissue inflammation by pro-resolving lipid mediators.
Clark M, Suur BE, Soták M, Börgeson E.
europepmc +1 more source
Cytokine release syndrome and CAR T Cell therapy: Modulating the intensity of the inflammatory response and resolution within the tumor microenvironment. [PDF]
Driscoll DF, Bistrian BR.
europepmc +1 more source
Inflammation-resolution signalling in cardiac repair, remodelling, and heart failure. [PDF]
Halade GV, Bäck M, Kain V.
europepmc +1 more source

